Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Amicus Therapeutics, Inc. - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
FOLD
Nasdaq
8731
https://www.amicusrx.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Amicus Therapeutics, Inc.
7 Stocks Most Likely to Follow in WeWork’s Woeful Footsteps
- Nov 15th, 2023 2:48 pm
Amicus Therapeutics, Inc. (NASDAQ:FOLD): Are Analysts Optimistic?
- Nov 11th, 2023 2:12 pm
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Q3 2023 Earnings Call Transcript
- Nov 10th, 2023 3:07 pm
Amicus' (FOLD) Q3 Loss Narrows, Galafold Sales View Updated
- Nov 9th, 2023 6:02 pm
Amicus Therapeutics Announces Third Quarter 2023 Financial Results and Corporate Updates
- Nov 8th, 2023 12:00 pm
Insider Sell: Amicus Therapeutics Inc President and CEO Bradley Campbell Sells 11,700 Shares
- Nov 4th, 2023 9:03 am
Synlogic, Inc. (SYBX) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
- Nov 2nd, 2023 2:00 pm
Amicus Therapeutics (FOLD) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
- Nov 1st, 2023 2:01 pm
Amicus Therapeutics to Present at Upcoming Investor Conferences in November 2023
- Nov 1st, 2023 11:00 am
Amicus Therapeutics to Announce Third Quarter 2023 Financial Results on November 8, 2023
- Oct 27th, 2023 11:00 am
This Rare Disease Pharma Is a Hidden Gem
- Oct 8th, 2023 11:00 am
‘Stay Invested Through the Uncertainty’: J.P. Morgan Says Stocks Could Reach New Highs Next Year — Here Are 2 Names to Pounce on Now
- Oct 5th, 2023 11:45 pm
Insider Sell: Amicus Therapeutics Inc President & CEO Bradley Campbell Sells 11,700 Shares
- Oct 5th, 2023 7:01 am
Amicus Therapeutics Announces Presentation and Posters at World Muscle Society 2023
- Oct 3rd, 2023 11:00 am
Amicus Therapeutics and Blackstone Enter into $430 Million Strategic Financing Collaboration
- Oct 2nd, 2023 12:20 pm
Amicus (FOLD) Gets FDA Approval for Pompe Disease Drug
- Sep 29th, 2023 1:09 pm
UPDATE 1-US FDA approves Amicus Therapeutics' muscle disorder treatment
- Sep 28th, 2023 3:08 pm
Amicus Therapeutics Announces FDA Approval and Launch of New Treatment for Pompe Disease
- Sep 28th, 2023 2:41 pm
Amicus Therapeutics Stock Reaches 80+ Relative Strength Benchmark
- Sep 28th, 2023 2:32 pm
Zacks.com featured highlights include Amicus Therapeutics, Genius Sports and Viad
- Sep 21st, 2023 12:42 pm
Scroll